Determination of levetiracetam in human plasma/serum/saliva by liquid chromatography-electrospray tandem mass spectrometry
- 31 January 2007
- journal article
- research article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 375 (1-2), 115-118
- https://doi.org/10.1016/j.cca.2006.06.022
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- High‐performance liquid chromatographic determination of Levetiracetam in human plasma: comparison of different sample clean‐up proceduresBiomedical Chromatography, 2003
- Levetiracetam: Relative Bioavailability and Bioequivalence of a 10% Oral Solution (750 mg) and 750‐mg TabletsThe Journal of Clinical Pharmacology, 2003
- Analysis of the antiepileptic drug keppra by capillary electrophoresisJournal of Chromatography A, 2003
- A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trialsEpilepsy & Behavior, 2003
- Correlation of Levetiracetam Concentrations Between Serum and SalivaTherapeutic Drug Monitoring, 2003
- Enantioselective analysis of levetiracetam and its enantiomer R-α-ethyl-2-oxo-pyrrolidine acetamide using gas chromatography and ion trap mass spectrometric detectionJournal of Chromatography B: Biomedical Sciences and Applications, 2000
- Pharmacokinetic profile of levetiracetam: toward ideal characteristicsPharmacology & Therapeutics, 2000
- The Clinical Pharmacokinetics of the Newer Antiepileptic DrugsClinical Pharmacokinetics, 1996
- A Micromethod for the Determination of the New Antiepileptic Drug Levetiracetam (ucb LO59) in Serum or Plasma by High Performance Liquid ChromatographyTherapeutic Drug Monitoring, 1996
- High-performance liquid chromatographic and megabore gas—liquid chromatographic determination of levetiracetam (ucb L059) in human serum after solid-phase extractionJournal of Chromatography B: Biomedical Sciences and Applications, 1994